Phenytoin sodium (50 mg/ml inj) 2 ml vial: Discontinued
The 2 ml vials of phenytoin sodium (50 mg/ml inj) have been discontinued globally (Pharmacode: 391654).
Affected product
Pfizer discontinued its 2 ml vial of this product because there is not enough demand globally. All other presentations of phenytoin sodium remain available.
Phenytoin sodium
- Presentation: Inj 50 mg per ml, 2 ml ampoule
- Brand: Hospira
- Pharmacode: 391654
- Subsidy: $104.58
- Measure / Qty: per 5
Schedule listing for phenytoin sodium(external link)
HML listing for phenytoin sodium(external link)
Alternative product
The 5 ml vial remains available. Extra care may be needed for neonates or infants under 5kg when using the larger vial for a small dose.
Key dates
31 October 2025 | Last batch of the 2 ml vial expired
1 February 2026 | Product delisted from the Pharmaceutical Schedule
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)
Pharmac is a government agency. We do not sell medicines or related products.